tirzepatide faa approved Eli Lilly's Weight-Loss Drug Gets FDA Approval F.D.A. Approves New Obesity Drug

Know the response time you can expect

Increasing your injection dosage in a shorter period of time may result in unpleasant side effects in your gastrointestinal system

D.PatikJ

Studies show that weight regain is common within 12 months of discontinuing GLP-1 therapy, with many individuals regaining two-thirds of what they lost (PubMed)

You can read the full article at Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials

Eli Lilly told the firm it is not interested in exclusive "one-of-one" deals with PBMs, while Novo Nordisk said CVS approached the drugmaker about the Wegovy agreement, according to Seigerman